PUBLISHED DATE : May 2021 | Pages : 220
Fill out your details & get your free sample
Europe E-Prescribing Market Size, Share, Trends Analysis Report by Type (Standard E-prescribing and Electronic Prescribing for Controlled Substances (EPCS)); Delivery Mode (Web & Cloud-based and On-premise & Desktop); Modality (Integrated and Standalone), Medication Type (Cardiovascular, Anti-Infectives, Oncology, Pain Management, Behavioral & Mental health, and Others); End-User (Technology Vendors, Independent & Specialty Pharmacies, Healthcare Facilities, and Pharmacy Benefit Management (PBM) & Payors); and Geography (Europe); Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2026
220 Pages
25 Tables
105 Charts
1 Regions
11 Countries
11 Companies
6 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (Revenue) | USD 1 BILLION (2026) |
| CAGR | 23% (2021-2026) |
| Base Year | 2020 |
| Forecast Year | 2021 –2026 |
| Market Segments | Type (Standard and Electronic Prescribing for Controlled Substances (EPCS)), Delivery Mode (Web & Cloud-based and On-premise & Desktop), Modality (Integrated and Standalone), Medication Type (Cardiovascular, Anti-Infectives, Oncology, Pain Management, Behavioral & Mental health, and Others), End-User (Technology Vendors, Independent & Specialty Pharmacies, Healthcare Facilities, and Pharmacy Benefit Management (PBM) & Payors) |
| Geographic Analysis | Europe |
| Countries Covered | UK, Italy, Spain, Germany, France, Netherlands, Sweden, Denmark, Austria, Finland, and Others |
The Europe e-prescribing market to cross over USD 1 billion, growing at a CAGR of around 23% during the forecast period.
Telehealth services are among the second biggest eHealth trends in Europe after patient electronic health records. One of the significant factors driving the industry growth is the growing awareness and acceptance of remote monitoring solutions and increasing technological advances. For example, in March 2020, Germany performed more than 19,500 teleconsultations. In Norway, the share of e-consultations was almost 60%. France is a successful example of telehealth adoption, with nearly ten years of successful telehealth legislation in place. Artificial intelligence to transform the digital prescription technology market in Europe. Big data analytics and machine learning algorithms for analyzing large-scale EMRs data are developed to understand the way prescribers treat patients automatically in real-life scenarios. For instance, AI helps prevent drug overdose by utilizing the medication history to predict the potential for opioid overdose priorly, augmenting the efforts of clinicians to detect such life-threatening risks.
E-prescription to compliment cross-border healthcare across Europe.
An eHealth Digital Service Infrastructure (eHDSI) was developed to ensure the continuity of care for European citizens traveling abroad in the EU. The eHDSI is giving EU countries the opportunity to exchange health data in an efficient, secure, and interoperable manner. E-prescribing in independent and specialty pharmacies is gaining immense traction. Independent and specialty pharmacies accounted for around 13% of the Europe e-prescribing market share in 2020.
The Europe e-prescribing market research report includes detailed segmentation by
The standard e-prescribing segment to grow at a CAGR of around 23% by 2026.
The standard segment accounted for a share of over 94% in the Europe e-prescribing market in 2020. Standard e-prescribing system is a robust technology facilitating an interactive data transaction. These transactions in standard software allow prescribers to view a complete medication list of patients. E-prescribing enhances the efficiency and effectiveness of patient care through automated clinical decision support and tracking of complete medication profiles. Such tools can reduce patient risk towards drugs by identifying them automatically.
The use of EPCS can potentially reduce prescription drug abuse. It has produced new identity proofing responsibilities for EHR vendors, providers, and prescribers through two-factor authentication, strict auditing methods, and more robust audit trails. EPCS can significantly reduce the burden on patients by avoiding multiple visits between pharmacies and providers for prescriptions or otherwise in need of treatment with controlled substances. Several healthcare providers are likely to adopt EPCS to stay in compliance and improve their prescribing processes.
Web & cloud-based e-prescription market to witness an incremental growth of over USD 640 million.
Cloud and web-based systems are highly preferred than on-premise as it does not require complex installation processes to set up intense infrastructure to host data. One of the major reasons for the high adoption of web-based solutions is that it can be done through the internet without IT support and minimizes additional costs. Cloud services enable the ability to access healthcare data from different locations and across multiple devices. It can access and process EHRs, collect data, and visualize diagnostic images in various resolutions.
The integrated modality segment is likely to grow at the highest CAGR during the forecast period.
The integrated e-prescribing solutions are in high demand and accounting for a significant share of over 88% in the modality segment. Integrated solutions can improve patient safety and communication with providers. It provides real-time, patient-centered records that are instant, secure, and accessible only by authorized users at a medical practice and provide a broad view of the care a patient has received. Vendors are increasingly focusing on adopting the integration of EHR into their e-prescribing solutions. Emerging players are offering integrated services, which is contributing to its wider acceptance.
Cardiovascular accounted for the second largest industry share in the European e-prescribing market.
Cardiovascular drugs are the most commonly e-prescribing medications mainly due to the fact of the increasing prevalence of cardiovascular diseases. These remain the leading cause of mortality and a significant cause of morbidity in Europe, causing 45% of all deaths in Europe and 37% in the European Union. The medication type segment includes cardiovascular, anti-infectives, oncology, pain management, behavioral and mental health, and others. With the growing burden of various diseases, the consumption of drugs has drastically increased. E-prescription has emerged as an effective solution to control the overuse of medications and prevent adverse drug events associated with their overdose. It has successfully proven to reduce such adverse events by limiting the prescribing of drugs and monitoring their usage simultaneously.
Technology vendors accounted for a substantial share of 72% in 2020.
The interest in digital health and related technologies increased rapidly in clinical medicine as well as biomedical research and drug discovery. Vendors are customizing their telehealth services by including e-prescribing. E-prescription integrated with advanced telehealth solutions can be used for routine check-ups or prescription refills. Some telehealth services are integrated with EHR to allow electronic prescription.
Pharmacies are increasingly utilizing ePrescribing solutions due to their several benefits. This allows pharmacies to stay competitive with larger chain pharmacies and reduce the time needed to process prescriptions. Pharmacy software incorporated with e-prescribing has turned into a game-changer for independent pharmacies that are planning to drive business improvements.
EU-5 countries accounted for more than 50% of the revenue share of the e-prescribing market in Europe.
In EU-5, a growing number of healthcare organizations are actively involved in the adoption of digitized services that include eHealth, telemedicine, e-prescribing, EHRs, and others. With such advancements, EU-5 is projected to grow at a lucrative rate due to the increasing demand for EHRs and online prescribing services, favourable governmental policies, and increasing healthcare expenditures.
The rest of Europe has considerable growth potential in the e-prescribing market due to ongoing government initiatives at the country level on implementing and mandating the use of electronic prescribing of medications. Other factors such as the prevalence of chronic illness, demand for online pharmacy & prescriptions, increased concerns of reducing medication errors, healthcare expenditures, and adoption of EHRs for telehealth services are boosting the use of electronic prescription in the region.
Surescripts, one of the leading e-prescribing solutions, accounted for more than 50% of the market share in 2020.
The e-prescribing market in Europe consists of some prominent players, including Surescripts, Henry Schein, Aegis Healthcare, DrChrono, SISGAIN, CarePaths, eClinicalWorks, CGI, and Change Healthcare which contributing to the growth of the market in Europe. The market is likely to witness a rise and increased competition due to the emergence of mid-sized players and start-ups after the comprehensive implementation of online prescribing services across Europe. In coming years, European countries are likely to witness high growth as favourable government initiatives will mandate electronic prescribing software.
The Europe e-prescribing market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:
Segmentation by Type
Segmentation by Delivery mode
Segmentation by Modality
Segmentation by Medication
Segmentation by End-users
Segmentation by Geography
Frequently Asked Questions
How big is the European e-prescribing market?
The Europe e-prescribing market size to cross over USD 1 billion by 2026.
What is the e-prescribing market growth rate?
The Europe e-prescribing market size to grow at a CAGR of around 23% during 2020-2026.
Who are the key players in the European e-prescribing market?
Surescripts, Henry Schein, Aegis Healthcare, DrChrono, Sisgain, Carepaths, Clinicalworks, and CGI are the key players in the Europe e-prescribing market.
Which segment accounted for the largest ePrescribing market share?
Web & cloud-based e-prescription accounted for a significant share and is likely to witness the highest incremental growth during the forecast period.
What are the key driving factors for the E-Prescribing Market?
Growing adoption of telehealth services in Europe, artificial intelligence to eradicate prescription error normalizing cross-border healthcare via new e-prescription paradigms, and favorable programs for high penetration of EHR are the key driving factors of the market
Europe e-prescribing market size is expected to grow at a CAGR of around 23% during 2020-2026
The following factors are likely to contribute to the growth of the European e-prescription market during the forecast period:
Base Year: 2020
Forecast Year: 2021–2026
The report considers the present scenario of the Europe e-prescribing market and its market dynamics for the period 2021−2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.
Key Vendors
Other Prominent Vendors
Segmentation by Type
Segmentation by Delivery mode
Segmentation by Modality
Segmentation by Medication
Segmentation by Geography
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of The Study
4.3.1 Market Segmentation by Type
4.3.2 Market Segmentation by Delivery Mode
4.3.3 Market Segmentation by Modality
4.3.4 Market Segmentation by Medication Type
4.3.5 Market Segmentation by End-user
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
7.1.1 Features of an ideal e-prescribing system
7.1.2 Standards for Electronic Prescription Systems
7.1.3 State of E-prescribing in Europe
8 Market Opportunities & Trends
8.1 Growing Adoption of Telehealth Services In Europe
8.2 AI To Eradicate Prescription Errors
8.3 Normalizing Cross-Border Healthcare Via New E-Prescription Paradigms In Europe
9 Market Growth Enablers
9.1 Reducing Handwritten Prescriptions & Errors
9.2 Favorable Programs For High EHR Penetration
9.3 Initiatives For Adopting E-Prescribing In Europe
9.4 Healthcare Payors Influencing E-Prescribing Decisions
10 Market Restraints
10.1 Issues Regarding Security & Data Breach
10.2 Lack Of Standardization & Inadequate Training For Clinicians
10.3 Incompatible Software Systems & Complex Technologies
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Impact of COVID-19 in Europe
11.4 Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Type
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Standard E-Prescribing
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 EPCS
12.4.1 Market Overview
12.4.2 Market Size & Forecast
13 Delivery Mode
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Web & Cloud-Based
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 On-Premise & Desktop
13.4.1 Market Overview
13.4.2 Market Size & Forecast
14 Modality
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Integrated
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Standalone
14.4.1 Market Overview
14.4.2 Market Size & Forecast
15 Medication Type
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Cardiovascular
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.4 Anti-Infectives
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.5 Oncology
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.6 Pain Medication
15.6.1 Market Overview
15.6.2 Market Size & Forecast
15.7 Behavioral & Mental Health
15.7.1 Market Overview
15.7.2 Market Size & Forecast
15.8 Others
15.8.1 Market Overview
15.8.2 Market Size & Forecast
16 End-User
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
16.3 Technology Vendors
16.3.1 Market Overview
16.3.2 Market Size & Forecast
16.4 Independent & Specialty Pharmacies
16.4.1 Market Overview
16.4.2 Market Size & Forecast
16.5 Healthcare Facilities
16.5.1 Market Overview
16.5.2 Market Size & Forecast
16.6 PBM & PAYORS
16.6.1 Market Overview
16.6.2 Market Size & Forecast
17 Geography
17.1 Market Snapshot & Growth Engine
17.2 Geographic Overview
18 EU-5
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 UK: Market Size & Forecast
18.3.2 Italy: Market Size & Forecast
18.3.3 Spain: Market Size & Forecast
18.3.4 Germany: Market Size & Forecast
18.3.5 France: Market Size & Forecast
19 Rest of Europe
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Key Countries
19.3.1 Netherlands: Market Size & Forecast
19.3.2 Sweden: Market Size & Forecast
19.3.3 Denmark: Market Size & Forecast
19.3.4 Austria: Market Size & Forecast
19.3.5 Finland: Market Size & Forecast
19.3.6 Others: Market Size & Forecast
20 Competitive Landscape
20.1 Competition Overview
20.2 Market Share Analysis
20.2.1 Surescripts
20.2.2 Henry Schein
20.2.3 Aegis Healthcare
20.2.4 DrChrono
20.2.5 SISGAIN
20.2.6 CarePaths
20.2.7 eClinicalWorks
20.2.8 CGI
20.2.9 Change Healthcare
21 Key Company Profiles
21.1 Surescripts
21.1.1 Business Overview
21.1.2 Surescripts in E-prescribing Market
21.1.3 Product Offerings
21.1.4 Key Strategies
21.1.5 Key Strengths
21.1.6 Key Opportunities
21.2 Henry Schein
21.2.1 Business Overview
21.2.2 Henry Schein In E-Prescribing Market
21.2.3 Product Offerings
21.2.4 Key Strategies
21.2.5 Key Strengths
21.2.6 Key Opportunities
21.3 Aegis Healthcare
21.3.1 Business Overview
21.3.2 Aegis Healthcare in E-prescribing Market
21.3.3 Product Offerings
21.3.4 Key Strategies
21.3.5 Key Strengths
21.3.6 Key Opportunities
21.4 DrChrono
21.4.1 Business Overview
21.4.2 DrChrono in E-prescribing Market
21.4.3 Product Offerings
21.4.4 Key Strategies
21.4.5 Key Strengths
21.4.6 Key Opportunities
21.5 SISGAIN
21.5.1 Business Overview
21.5.2 SISGAIN in E-prescribing Market
21.5.3 Product Offerings
21.5.4 Key Strategies
21.5.5 Key Strengths
21.5.6 Key Opportunities
21.6 CarePaths
21.6.1 Business Overview
21.6.2 CarePaths in E-prescribing Market
21.6.3 Product Offerings
21.6.4 Key Strategies
21.6.5 Key Strengths
21.6.6 Key Opportunities
21.7 eClinicalWorks
21.7.1 Business Overview
21.7.2 eClinicalWorks in E-prescribing Market
21.7.3 Product Offerings
21.7.4 Key Strategies
21.7.5 Key Strengths
21.7.6 Key Opportunities
21.8 CGI
21.8.1 Business Overview
21.8.2 CGI in E-prescribing Market
21.8.3 Product Offerings
21.8.4 Key Strategies
21.8.5 Key Strengths
21.8.6 Key Opportunities
21.9 Change Healthcare
21.9.1 Business Overview
21.9.2 Change Healthcare in E-prescribing Market
21.9.3 Product Offerings
21.9.4 Key Strategies
21.9.5 Key Strengths
21.9.6 Key Opportunities
22 Other Prominent Vendors
22.1 Nortal
22.1.1 Business Overview
22.1.2 Product Offerings
22.2 Medicata
22.2.1 Business Overview
22.2.2 Product Offerings
23 Report Summary
23.1 Key Takeaways
23.2 Strategic Recommendations
24 Quantitative Summary
24.1 Market By Delivery Mode
24.2 Market By Type
24.3 Market By Modality
24.4 Market Medication Type
24.5 Market By End-User
25 Appendix
25.1 Abbreviations
List of Exhibits
Exhibit 1 Segmentation of E-Prescribing Market in Europe
Exhibit 2 Market Size Calculation Approach 2020
Exhibit 3 Workflow Map of e-Prescribing Process in Pharmacies
Exhibit 4 Impact of Growing Adoption of Telehealth Services in Europe
Exhibit 5 Impact of AI to Eradicate Prescription Errors
Exhibit 6 Impact of Normalizing Cross-border Healthcare via New e-Prescription Paradigms in Europe
Exhibit 7 Impact of Reducing Handwritten Prescriptions & Errors
Exhibit 8 Impact of Favorable Programs for High EHR Penetration
Exhibit 9 Impact of Initiatives for Adopting e-Prescribing in Europe
Exhibit 10 Impact of Healthcare Payors Influencing e-Prescribing Decisions
Exhibit 11 Impact of Issues Regarding Security & Data Breach
Exhibit 12 Impact of Lack of Standardization & Inadequate Training for Clinicians
Exhibit 13 Impact of Incompatible Software Systems & Complex Technologies
Exhibit 14 E-prescribing Market in Europe 2020–2026 ($ million)
Exhibit 15 E-prescribing Market in Europe by Geography
Exhibit 16 E-prescribing Market in Europe by Type
Exhibit 17 E-prescribing Market in Europe by Delivery Mode
Exhibit 18 E-prescribing Market in Europe by Modality
Exhibit 19 E-prescribing Market in Europe by Medication Type
Exhibit 20 E-prescribing Market in Europe by End-user
Exhibit 21 COVID-19 Impact on Telemedicine Adoption in EU countries
Exhibit 22 Five Forces Analysis 2020
Exhibit 23 Incremental Growth by Type 2020 & 2026
Exhibit 24 E-prescribing Market in Europe by Type
Exhibit 25 E-prescribing Market in Europe by Type: Incremental Growth
Exhibit 26 E-prescribing Market in Europe by Type: Absolute Growth
Exhibit 27 Standard E-prescribing Market in Europe: Incremental & Absolute Growth
Exhibit 28 Standard E-prescribing Market in Europe 2020–2026 ($ million)
Exhibit 29 Non-medical Prescription Opioid Use in European Countries (2014)
Exhibit 30 EPCS Market in Europe: Incremental & Absolute Growth
Exhibit 31 EPCS Market in Europe 2020–2026 ($ million)
Exhibit 32 Incremental Growth by Delivery Mode 2020 & 2026
Exhibit 33 E-prescribing Market in Europe by Delivery Mode
Exhibit 34 E-prescribing Market in Europe by Delivery Mode: Incremental Growth
Exhibit 35 E-prescribing Market in Europe by Delivery Mode: Absolute Growth
Exhibit 36 Web & Cloud-based E-prescribing Market in Europe: Incremental & Absolute Growth
Exhibit 37 Web & Cloud-based E-prescribing Market in Europe 2020–2026 ($ million)
Exhibit 38 On-premise & Desktop E-prescribing Market in Europe: Incremental & Absolute Growth
Exhibit 39 On-Premise & Desktop E-prescribing Market in Europe 2020–2026 ($ million)
Exhibit 40 Incremental Growth by Modality 2020 & 2026
Exhibit 41 E-prescribing Market in Europe by Modality
Exhibit 42 E-prescribing Market in Europe by Modality: Incremental Growth
Exhibit 43 E-prescribing Market in Europe by Modality: Absolute Growth
Exhibit 44 Integrated E-prescribing Market in Europe: Incremental & Absolute Growth
Exhibit 45 Integrated E-prescribing Market in Europe 2020–2026 ($ million)
Exhibit 46 Standalone E-prescribing Market in Europe: Incremental & Absolute Growth
Exhibit 47 Standalone E-prescribing Market in Europe 2020–2026 ($ million)
Exhibit 48 Incremental Growth by Medication Type 2020 & 2026
Exhibit 49 E-prescribing Market in Europe by Medication Type
Exhibit 50 E-prescribing Market in Europe by Medication Type: Incremental Growth
Exhibit 51 E-prescribing Market in Europe by Medication Type: Absolute Growth
Exhibit 52 Cardiovascular E-prescribing Market in Europe: Incremental & Absolute Growth
Exhibit 53 Cardiovascular E-prescribing Market in Europe 2020–2026 ($ million)
Exhibit 54 Anti-infectives E-prescribing Market in Europe: Incremental & Absolute Growth
Exhibit 55 Anti-infectives E-prescribing Market in Europe 2020–2026 ($ million)
Exhibit 56 Oncology E-prescribing Market in Europe: Incremental & Absolute Growth
Exhibit 57 Oncology E-prescribing Market in Europe 2020–2026 ($ million)
Exhibit 58 Commonly Used Controlled Substances in Europe
Exhibit 59 Pain Medication E-prescribing Market in Europe: Incremental & Absolute Growth
Exhibit 60 Pain Medication E-prescribing Market in Europe 2020–2026 ($ million)
Exhibit 61 Behavioral & Mental Health E-prescribing Market in Europe: Incremental & Absolute Growth
Exhibit 62 Behavioral & Mental Health E-prescribing Market in Europe 2020–2026 ($ million)
Exhibit 63 Other E-prescribing Market in Europe: Incremental & Absolute Growth
Exhibit 64 Other E-prescribing Market in Europe 2020–2026 ($ million)
Exhibit 65 Incremental Growth by End-user 2020 & 2026
Exhibit 66 E-prescribing Market in Europe by End-User
Exhibit 67 E-prescribing Market in Europe by End-user: Incremental Growth
Exhibit 68 E-prescribing Market in Europe by End-user: Absolute Growth
Exhibit 69 E-prescribing Technology Vendors Market in Europe: Incremental & Absolute Growth
Exhibit 70 E-prescribing Technology Vendors Market in Europe 2020–2026 ($ million)
Exhibit 71 Number of Pharmacies in Major European Countries (2015)
Exhibit 72 E-prescribing Independent & Specialty Pharmacies Market in Europe: Incremental & Absolute Growth
Exhibit 73 E-prescribing Independent & Specialty Pharmacies Market in Europe 2020–2026 ($ million)
Exhibit 74 Rate of e-Prescribing in Primary Healthcare Facilities in Europe (2002–2013)
Exhibit 75 E-prescribing Healthcare Facilities Market in Europe: Incremental & Absolute Growth
Exhibit 76 E-prescribing Healthcare Facilities Market in Europe 2020–2026 ($ million)
Exhibit 77 E-prescribing PBM & Payors Market in Europe: Incremental & Absolute Growth
Exhibit 78 E-prescribing PBM & Payors Market in Europe 2020–2026 ($ million)
Exhibit 79 Incremental Growth by Geography 2020 & 2026
Exhibit 80 E-prescribing Market in Europe by Geography
Exhibit 81 E-prescribing Market in Europe by Geography: Incremental Growth
Exhibit 82 E-prescribing Market in Europe by Geography: Absolute Growth
Exhibit 83 E-prescribing Market in EU-5: Key Countries
Exhibit 84 Market Share of Major Countries in EU-5
Exhibit 85 Growth of e-Prescribing in Primary Care in EU-5 Countries
Exhibit 86 E-prescribing Market in EU-5: Incremental & Absolute Growth
Exhibit 87 E-prescribing Market in EU-5 2020–2026 ($ million)
Exhibit 88 Incremental Growth in EU-5 2020 & 2026
Exhibit 89 E-prescribing Market in UK 2020–2026 ($ million)
Exhibit 90 E-prescribing Market in Italy 2020–2026 ($ million)
Exhibit 91 E-prescribing Market in Spain 2020–2026 ($ million)
Exhibit 92 E-prescribing Market in Germany 2020–2026 ($ million)
Exhibit 93 E-prescribing Market in France 2020–2026 ($ million)
Exhibit 94 Market Share of Major Countries in Rest of Europe (%)
Exhibit 95 Growth of e-Prescribing in Primary Care in Rest of Europe (%)
Exhibit 96 E-prescribing Market in Rest of Europe: Incremental & Absolute Growth
Exhibit 97 E-prescribing Market in Rest of Europe 2020–2026 ($ million)
Exhibit 98 Incremental Growth in Rest of Europe 2020 & 2026
Exhibit 99 E-prescribing Market in Netherlands 2020–2026 ($ million)
Exhibit 100 E-prescribing Market in Sweden 2020–2026 ($ million)
Exhibit 101 E-prescribing Market in Denmark 2020–2026 ($ million)
Exhibit 102 E-prescribing Market in Austria 2020–2026 ($ million)
Exhibit 103 E-prescribing Market in Finland 2020–2026 ($ million)
Exhibit 104 E-prescribing Market in Other European Countries 2020–2026 ($ million)
Exhibit 105 E-Prescribing Market in Europe: Vendors Market Share 2020
List of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2020
Table 3 Cross-border e-Prescription Services Available in EU
Table 4 Pros & Cons for Standalone & Integrated E-prescribing Solutions
Table 5 Surescripts: Major Product Offerings
Table 6 Henry Schein: Major Product Offerings
Table 7 Aegis Healthcare: Major Product Offerings
Table 8 DrChrono: Major Product Offerings
Table 9 SISGAIN: Major Product Offerings
Table 10 CarePaths: Major Product Offerings
Table 11 eClinicalWorks: Major Product Offerings
Table 12 CGI: Major Product Offerings
Table 13 Change Healthcare: Major Product Offerings
Table 14 Nortal: Major Product Offerings
Table 15 Medicata: Major Product Offerings
Table 16 E-Prescribing Market in Europe by Delivery Mode 2020−2026 ($ million)
Table 17 E-Prescribing Market in Europe by Delivery Mode 2020−2026 (%)
Table 18 E-Prescribing Market in Europe by Type 2020−2026 ($ million)
Table 19 E-Prescribing Market in Europe by Type 2020−2026 (%)
Table 20 E-Prescribing Market in Europe by Modality 2020−2026 ($ million)
Table 21 E-Prescribing Market in Europe by Modality 2020−2026 (%)
Table 22 E-Prescribing Market in Europe by Medication Type 2020−2026 ($ million)
Table 23 E-Prescribing Market in Europe by Medication Type 2020−2026 (%)
Table 24 E-Prescribing Market in Europe by End-user 2020−2026 ($ million)
Table 25 E-Prescribing Market in Europe by End-user 2020−2026 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
